Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial and fungal cell wall and membrane structures are essential protective barriers that maintain cellular integrity and regulate the transport of molecules [1]. In bacteria, the cell wall is primarily composed of peptidoglycan, a complex polymer of sugars and amino acids, while the outer membrane of Gram-negative bacteria contains lipopolysaccharides [2]. Fungal cell walls are distinct, consisting of chitin, glucans, and mannoproteins, with membranes containing ergosterol instead of cholesterol [3]. These structures are critical for survival against osmotic pressure and environmental stress, making them ideal targets for antimicrobial therapy [4]. Drugs targeting these structures, such as beta-lactams, glycopeptides, and echinocandins, exploit the fundamental differences between microbial and host cell architecture to achieve selective toxicity [5]. Disruption of these components typically leads to cell lysis or growth inhibition, though the emergence of resistance and potential toxicity to host tissues remain significant clinical challenges [6]. Furthermore, the presence of these structures often triggers host immune responses, serving as pathogen-associated molecular patterns (PAMPs) [1, 3]. Understanding the molecular assembly of these envelopes is crucial for developing next-generation antibiotics and antifungals to combat multi-drug resistant pathogens [6].
Inhibition of peptidoglycan biosynthesis; Disruption of cell membrane integrity; Inhibition of 1,3-beta-D-glucan synthesis; Binding to ergosterol to create trans-membrane pores; Inhibition of lanosterol 14-alpha-demethylase.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and fungal cell wall and membrane structures.